Eisai is a research-based human health care company that discovers, develops, packages, and markets pharmaceutical products with a focus on neurology, oncology, Alzheimer's disease, epilepsy, and metabolic disorders. It offers a portfolio of tablets and injections for the treatment of various diseases. The company‘s areas of research and development focus include neuroscience, oncology, vascular, inflammatory and immunological reaction, and antibody-based programs.